Sort
64,565 grants matching “drug discovery”
Mitogenic and Oncogenic Regulation of ERK/RSK Signaling
$669,027John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA
High-Throughput Screening Platform for Cancer Drug Discovery
$669,017Anne Plochowietz · Palo Alto Research Center · R33 · FY2021 · CA
Systems Genetics of Adiposity Traits in Outbred Rats
$668,810Leah Catherine Solberg Woods · Medical College Of Wisconsin · R01 · FY2015 · DK
Neuron-Keratinocyte Communication in the Epidermis in Normal and Diabetic Wound Healing
$668,797Amy S Paller · Northwestern University At Chicago · R01 · FY2023 · AR
Advancing Knowledge Discovery for Postoperative Pain Management
$668,723Tina Hernandez-Boussard · Stanford University · R01 · FY2019 · LM
Chemical disarming of drug resistance in Mycobacterium tuberculosis
$668,717Christina Leigh Stallings · Washington University · R01 · FY2018 · AI
Non Alcoholic Steatohepatitis Clinical Research Network
$668,701Srinivasan Dasarathy · Cleveland Clinic Lerner Com-Cwru · U01 · FY2023 · DK
Data Coordination and Integration Center for LINCS-BD2K
$668,701Avi Ma'ayan · Icahn School Of Medicine At Mount Sinai · U54 · FY2016 · HL
NEW ANTICANCER DRUGS FOR CULTURED AND COLLECTED MARINE O
$668,682University Of California San Diego · U19 · FY2001 · CA
Measure the metabolic and genetic factors that determine M. Tuberculosis
$668,601David Branch Moody · Brigham And Women'S Hospital · U19 · FY2021 · AI
Genetic Variation and Evolution of Artemisinin Resistance
$668,571Dyann F Wirth · Harvard School Of Public Health · R01 · FY2015 · AI
A Reliable Switched Angle Spinning (SAS) Probe with Gradients (PFG) for Proteins in Solid-State NMR
$668,446Francis David Doty · Doty Scientific, Inc. · R44 · FY2022 · GM
Biology and vulnerabilities of POU2F3+ tuft cell-like carcinomas
$668,427Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2024 · CA
MPS Qualifications Section
$668,403Edward J Kelly · University Of Washington · U2C · FY2024 · TR
Targeting cardiovascular events to improve patient outcomes after sepsis
$668,389Allan J. Walkey · Boston University Medical Campus · R01 · FY2021 · HL
Ultrasound-Mediated Blood-Brain Barrier Permeabilization in Primates
$668,381Matthew Swan Lawrence · Virscio, Inc. · R44 · FY2009 · NS
Novel molecular therapeutics for cystic fibrosis
$668,380David E Sterner · Progenra, Inc. · R44 · FY2014 · HL
L1 retrotransposon-based mutagenesis for rat models of human diseases
$668,320Eric M Ostertag · Transposagen Biopharmaceuticals, Inc. · R44 · FY2008 · RR
High-dimensional Modeling of PET for radiomic Biomarker Discovery
$668,225Ani Eloyan · Brown University · R01 · FY2024 · AG
Development of soluble epoxide hydrolase inhibitors for the treatment of Alzheimer's disease
$668,220Kin Sing Stephen Lee · Michigan State University · R01 · FY2025 · AG
Microphysiological Human Tissue Systems for Monitoring of Genome Editing Outcomes
$668,150Charles A Gersbach · Duke University · U01 · FY2022 · HL
Microphysiological Human Tissue Systems for Monitoring of Genome Editing Outcomes
$668,150Charles A Gersbach · Duke University · U01 · FY2019 · EB
Microphysiological Human Tissue Systems for Monitoring of Genome Editing Outcomes
$668,150Charles A Gersbach · Duke University · U01 · FY2021 · HL
Animal Model and Microbiology Core
$668,131Andrew Nelson · Hackensack University Medical Center · U19 · FY2025 · AI
Integrated Platform for Discovery and Validation of Probes that Restore Protein Expression in Single-Gene Causes of Autism and Related Disorders
$668,094Gavin R Rumbaugh · Scripps Florida · R01 · FY2020 · MH